5-Year Data Show Mitomycin-C Approach Before TURBT Significantly Reduces Recurrence Risk in NMIBCByCaroline SeymourMay 17th 2026
Detalimogene Voraplasmid Hits High Complete Response Rate in BCG-Unresponsive NMIBCByCourtney FlahertyMay 16th 2026
Durvalumab-Based Regimen Delivers Significant DFS Boost in High-Risk NMIBCByCaroline SeymourMay 15th 2026